How to buy Clarity Pharmaceuticals (CU6) shares in Australia
Learn how to easily invest in Clarity Pharmaceuticals shares.
Clarity Pharmaceuticals is a biotechnology business based in Australia. Clarity Pharmaceuticals shares (CU6) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Clarity Pharmaceuticals has a trailing 12-month revenue of around $9.8 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Clarity Pharmaceuticals
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Clarity Pharmaceuticals. Find the share by name or ticker symbol: CU6. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Clarity Pharmaceuticals reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Clarity Pharmaceuticals. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
What's in this guide?
- Clarity Pharmaceuticals key stats
- Compare share trading platforms
- Is Clarity Pharmaceuticals stock a buy or sell?
- Clarity Pharmaceuticals performance over time
- Clarity Pharmaceuticals's financials
- How volatile are Clarity Pharmaceuticals shares?
- Does Clarity Pharmaceuticals pay a dividend?
- Other common questions
Clarity Pharmaceuticals stock price (ASX:CU6)Use our graph to track the performance of CU6 stocks over time.
Clarity Pharmaceuticals shares at a glance
|52-week range||$0.675 - $1.505|
|50-day moving average||$1.1478|
|200-day moving average||$0.9251|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.1|
Compare share trading platforms
Is it a good time to buy Clarity Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Clarity Pharmaceuticals price performance over time
|1 week (2023-11-30)||0.35%|
|1 month (2023-11-07)||27.68%|
|3 months (2023-09-07)||36.19%|
|6 months (2023-06-07)||85.71%|
|1 year (2022-12-07)||48.19%|
|2 years (2021-12-07)||71.26%|
Clarity Pharmaceuticals financials
|Revenue TTM||$9.8 million|
|Gross profit TTM||$9.8 million|
|Return on assets TTM||-18.65%|
|Return on equity TTM||-30.48%|
|Market capitalisation||$373.4 million|
TTM: trailing 12 months
Clarity Pharmaceuticals share dividends
We're not expecting Clarity Pharmaceuticals to pay a dividend over the next 12 months.
Clarity Pharmaceuticals share price volatility
Over the last 12 months, Clarity Pharmaceuticals's shares have ranged in value from as little as $0.675 up to $1.505. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Clarity Pharmaceuticals's is 0.758. This would suggest that Clarity Pharmaceuticals's shares are less volatile than average (for this exchange).
Clarity Pharmaceuticals overview
Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, develops theranostic therapy and imaging products for the treatment of cancer in children and adults. Its lead product includes SARTATE, a targeted theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express somatostatin receptor 2. The company is also developing SAR-Bombesin, a pan cancer theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express gastrin releasing peptide receptor; and SAR-bisPSMA, a theranostic radiopharmaceutical used for diagnosing, staging, and treating cancers that express prostate specific membrane antigen. Clarity Pharmaceuticals Ltd was incorporated in 2010 and is based in Sydney, Australia.
Stocks similar to Clarity Pharmaceuticals
Clarity Pharmaceuticals in the news
Frequently asked questions
More guides on Finder
Shein IPO: How to invest in the Shein IPO
What you need to know about investing in Shein from Australia.
Best performing stocks on the ASX in 2023 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
Tiger Brokers review for Australians
If you're thinking of trading stocks with Tiger Brokers, check out our review of this online broker's fees, safety and pros and cons first.
How to buy Gol Linhas Aereas Inteligentes SA ADR (GOL) shares in Australia
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
How to buy Caltex Australia shares
Steps to owning and managing Caltex Australia shares from .
A beginner’s guide to Lego investing
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
The cheapest stock brokers in Australia (Dec 2023)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
What is the money market?
Learn about the money market and everyday consumer money market products.
Is investing in crowdfunding a safe investment?
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
The best trading platforms in Australia
Follow these tips to find the best share trading platform for you.
Ask an Expert